Identifying Cancers Impacted by CDK8/19

CDK8 and CDK19 Mediator kinases are transcriptional co-regulators implicated in several types of cancer. Small-molecule CDK8/19 inhibitors have recently entered or are entering clinical trials, starting with breast cancer and acute myeloid leukemia (AML). To identify other cancers where these novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Roninson, Igor B., Győrffy, Balázs, Mack, Zachary T., Shtil, Alexander A., Shtutman, Michael S., Chen, Mengqian, Broude, Eugenia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721656/
https://www.ncbi.nlm.nih.gov/pubmed/31382571
http://dx.doi.org/10.3390/cells8080821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721656/
https://www.ncbi.nlm.nih.gov/pubmed/31382571
http://dx.doi.org/10.3390/cells8080821

Ejemplares similares